MARKET INSIGHTS
Global Angelic Acid market size was valued at USD 295.4 million in 2024. The market is projected to grow from USD 318.7 million in 2025 to USD 523.9 million by 2032, exhibiting a CAGR of 7.3% during the forecast period.
Angelic acid is an unsaturated organic compound and a derivative of crotonic acid, primarily found in plants of the Apiaceae family. This monounsaturated fatty acid serves as a key intermediate in pharmaceutical synthesis and fragrance production. The compound exists in two isomeric forms (cis and trans), with applications ranging from flavoring agents to anti‑inflammatory drug formulations.
The market growth is driven by expanding pharmaceutical applications, particularly in synthesizing active pharmaceutical ingredients (APIs) for migraine medications and anti‑inflammatory drugs. While North America currently dominates consumption, Asia‑Pacific is emerging as the fastest‑growing region due to increasing pharmaceutical manufacturing capacity. Recent developments include BASF’s 2023 expansion of specialty chemicals production in China, which includes angelic acid derivatives for regional pharmaceutical customers.
Global Angelic Acid Market – View in Detailed Research Report
Top 10 Companies in the Global Angelic Acid Market
-
TCI (Tokyo Chemical Industry Co., Ltd.)
Headquarters: Tokyo, Japan
Key Offering: High‑purity angelic acid (98%–99%) for pharmaceutical intermediates and fine chemicals.
TCI’s reputation for rigorous quality control and its extensive distribution network positions it as a trusted supplier for large‑scale drug manufacturers. The company’s investment in continuous‑flow synthesis has reduced cycle times and lowered production costs, allowing it to maintain competitive pricing while meeting the stringent purity demands of global pharma clients.
Sustainability & Growth Initiatives:
- Implementation of closed‑loop solvent recovery systems to cut waste emissions.
- Strategic partnership with Japanese universities to explore bio‑based routes for angelic acid production.
- Expansion of the Asia‑Pacific manufacturing footprint to capture rising regional demand.
-
VWR International
Headquarters: West Chester, United States
Key Offering: Broad portfolio of specialty chemicals, including angelic acid for research laboratories and industrial applications.
VWR’s global logistics network and strong presence in North America give it an edge in delivering customized solutions to pharmaceutical and research clients. The company’s focus on digital ordering platforms has streamlined procurement for small‑to‑medium enterprises, expanding its market share beyond large‑scale users.
Sustainability & Growth Initiatives:
- Adoption of renewable energy sources across U.S. distribution centers.
- Investment in green chemistry training for its sales force.
- Launch of a dedicated research program on enzymatic synthesis of angelic acid.
-
EMMX Biotechnology
Headquarters: San Diego, United States
Key Offering: Advanced APIs incorporating angelic acid for anti‑inflammatory and migraine therapies.
EMMX’s niche focus on developing novel therapeutic agents positions it as a key player in the emerging segment of angelic acid‑based drugs. The company’s close collaboration with clinical research organizations accelerates the translation of laboratory findings into market‑ready products.
Sustainability & Growth Initiatives:
- Integration of biocatalytic processes to reduce carbon footprint.
- Participation in joint ventures with biotech startups for next‑generation drug discovery.
- Implementation of real‑time analytics to optimize synthesis yields.
-
3B Scientific
Headquarters: West Lafayette, United States
Key Offering: Specialty reagents, including high‑purity angelic acid for academic and industrial research.
3B’s strong presence in the U.S. research community allows it to supply cutting‑edge reagents to universities and pharmaceutical R&D labs. Its commitment to open‑source data on reagent performance enhances trust among scientific users.
Sustainability & Growth Initiatives:
- Adoption of biodegradable packaging for reagent shipments.
- Collaboration with environmental NGOs to benchmark chemical safety.
- Development of a digital platform for reagent lifecycle tracking.
-
Chengdu Laurelsci Tech
Headquarters: Chengdu, China
Key Offering: Cost‑effective angelic acid grades for the growing Chinese pharmaceutical sector.
By leveraging China’s robust manufacturing infrastructure, Chengdu Laurelsci has positioned itself as a key supplier for domestic drug developers. The company’s focus on local sourcing reduces lead times and mitigates supply chain risks.
Sustainability & Growth Initiatives:
- Implementation of a green‑chemistry‑based production line.
- Participation in China’s “Made in China 2025” initiative for specialty chemicals.
- Investment in AI‑driven process optimization to increase yield.
-
J & K SCIENTIFIC
Headquarters: Shanghai, China
Key Offering: Angelic acid for fine‑chemical and fragrance applications.
J & K’s dual focus on research and commercial production allows it to serve both niche fragrance developers and large‑scale pharmaceutical intermediates. Its strategic alliances with local universities fuel continuous innovation.
Sustainability & Growth Initiatives:
- Adoption of low‑energy catalytic processes.
- Partnership with Chinese environmental regulators to meet upcoming safety standards.
- Development of a circular supply chain for raw‑material sourcing.
-
Meryer (Shanghai) Chemical Technology
Headquarters: Shanghai, China
Key Offering: High‑purity angelic acid for pharmaceutical intermediates.
Meryer’s integration of advanced purification technologies ensures consistent product quality, a critical requirement for API manufacturers. The company’s regional expansion into Southeast Asia taps into emerging markets with growing pharmaceutical demand.
Sustainability & Growth Initiatives:
- Implementation of waste‑heat recovery systems.
- Collaboration with local universities on green‑synthesis research.
- Launch of a digital platform for supply‑chain transparency.
-
Energy Chemical
Headquarters: Shanghai, China
Key Offering: Angelic acid for both research and industrial applications.
Energy Chemical’s focus on cost efficiency and rapid scale‑up has made it a go‑to supplier for mid‑size manufacturers. Its emphasis on process optimization reduces production costs, allowing it to compete aggressively in price‑sensitive markets.
Sustainability & Growth Initiatives:
- Adoption of renewable energy sources for plant operations.
- Implementation of a closed‑loop water recycling system.
- Investment in modular production units to enable rapid deployment.
-
Shanghai Longsheng Chemical
Headquarters: Shanghai, China
Key Offering: Angelic acid for fragrance, flavor, and pharmaceutical intermediates.
Shanghai Longsheng’s diversified product mix allows it to capture multiple market segments. Its strategic location near major shipping hubs reduces logistics costs for international customers.
Sustainability & Growth Initiatives:
- Implementation of solvent‑recycling technologies.
- Participation in China’s “Green Chemistry” certification program.
- Development of a digital supply‑chain tracking system.
-
BASF
Headquarters: Ludwigshafen, Germany
Key Offering: Specialty chemicals, including angelic acid derivatives for pharmaceutical and fragrance applications.
BASF’s global R&D network and advanced manufacturing capabilities enable it to deliver high‑quality angelic acid derivatives. The company’s recent expansion in China reflects its commitment to serving the fast‑growing Asian market.
Sustainability & Growth Initiatives:
- Investment in bio‑based feedstocks for chemical synthesis.
- Launch of a carbon‑neutral production line in China.
- Collaboration with academic institutions on green‑synthesis methods.
Download FREE Sample Report: Global Angelic Acid Market – View in Detailed Research Report
Get Full Report: Global Angelic Acid Market – View in Detailed Research Report
Market Outlook (2026‑2034)
The Global Angelic Acid market is expected to reach approximately USD 603 million by 2034, based on a consistent growth trajectory from 2025 through 2032. The steady expansion of pharmaceutical manufacturing in emerging economies, coupled with the increasing adoption of green chemistry practices, will sustain demand. North America will continue to dominate consumption, but Asia‑Pacific’s share is projected to grow faster, driven by local production capacity and favorable government incentives for specialty chemicals.
Regulatory developments, particularly in the EU and the US, will shape product specifications, pushing manufacturers toward higher purity grades and stricter safety standards. Companies that can demonstrate compliance and offer scalable, cost‑effective production methods will capture larger market shares.
Future Trends
1. Biocatalytic Production – Enzyme‑driven synthesis of angelic acid will reduce reliance on petrochemical feedstocks, aligning with global sustainability goals.
2. Digital Supply Chains – Real‑time monitoring of raw‑material sourcing and production metrics will enhance transparency and reduce lead times.
3. AI‑Optimized Synthesis – Artificial intelligence will be leveraged to model reaction pathways, increasing yield and lowering costs.
4. Expanded Pharmaceutical Applications – New APIs targeting chronic inflammatory conditions and migraine relief will increase the compound’s importance in drug development.
5. Regulatory Harmonization – Global alignment of pharmacopeia standards will streamline market entry for manufacturers operating across multiple jurisdictions.
By aligning product development with these emerging dynamics, companies can position themselves at the forefront of the evolving Angelic Acid market.
- Top 10 Companies in the Lead Zirconium Titanate Market (2026): Market Leaders Powering Global Innovation - July 14, 2026
- Top 10 Companies in the Custom Heat Shrink Tubing Market (2026): Market Leaders Powering Global Innovation - July 14, 2026
- Top 10 Companies in the Natural Ethyl Oleate Market (2026): Market Leaders Powering Global Adoption - July 14, 2026